W.R. Berkley Cut Neutral in Latest Assessment But Still Stands Above Peers, BofA Securities Says

MT Newswires Live
04-02

W.R. Berkley (WRB) has been on a roll during 2025, with shares last closing just below their all-time high set during the previous session, although the commercial insurance and re-insurance firm may find it hard extending its gains much more, analysts at BofA Securities said Tuesday in a research note.

The BofA analysts, citing valuation, cut their stock rating for Berkley on Tuesday to neutral from buy while nudging the price target for the company's shares to $74 from $73 per share. The downgrade follows a 7.5% advance on Friday after W.R. Berkley disclosed plans by Mitsui Sumitomo Insurance to acquire a 15% stake in the company through open market purchases and private transactions with third parties.

Berkley finished Q1 trading at 3.0 times its estimated book value, nearly matching all-time highs reached in April 2006 and again in November 2022. As a group, property and casualty insurers are likely overvalued, the BofA analysts said, explaining they already have trimmed their ratings for most of its peers to underperform.

Berkley, however, probably enjoys some benefits its peers do not, with less exposure to casualty volatility and sufficient loss reserves, they said.

"We believe Berkley to be no more challenged from a loss trend perspective than the industry broadly, and maybe even less so," the BofA analysts said, adding Mitsui-Sumitomo's plans to buy shares on the open market should help stabilize the stock while the rest of the market rides through increased volatility.

The BofA analysts said their $74 price target for Berkley shares reflects a 30% premium to projected 2026 price-to-earnings ratio compared to its peers, growing to 10.9 times forward earnings from a 10.5 multiple previously. The stock also boasts "unique" stock-specific attributes that should keep it in front of the industry pack, they said.

Price: 70.60, Change: -0.56, Percent Change: -0.79

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10